The role of the immune system in cancer Flashcards

1
Q

What are the three stages of cancer and immune system? [3]

A

Elimination (immnune system kills cancer)

Equilibrium (cancer and immune system are in stale-mate

Escape: (cell evades immunosurveillance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the three phenotypes of cancer [3]

A

Immune-desert tumour: There is a tumour, but no T Cell army is present to mount an attack.

Inflamed tumour: Inhibition of various inflammatory molecules to avoid destruction and create an ideal environment

Immnune-excluded tumour: high immune cell density in the outer invasive margin and low density in the core

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe what checkpoint inhibition is [1]

State two key molecules influential in checkpoint inhibition [2]

A

Checkpoint inhibitors: take the brakes off the immune system; checkpoints inhibits the stop sign that a cancer cell usually presents to immune cells

Checkpoints (caused by)
PD1 Programmed Death Receptor 1
CTLA-4 Cytotoxic T-Lymphocyte Associated protein 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the role of the PD1 checkpoint [2]

A

PD1 regulates T cell activation through binding with the ligands programmed death-ligand 1 (PDL1) and programmed cell death 1 ligand 2 (PDL2)

This inhibits T cell proliferation and survival: helps prevent the immune system from attacking itself

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain the influence of cancer cells on PD1 checkpoint

A

Cancer cell can turn off the PD-1 pathway:
.
If PDL1 or PDL2 are expressed within the tumour microenvironment (TME), the ligands can bind to PD1, terminating TCR signalling and reducing the activation of T cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which drugs bind to PD-L1? [3]

A

Atezolizumab
Durvalumab
Avelumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which drugs bind to PD-1? [2]

A

Pembrolizumab
Nivolumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain the role of CTLA-4 [1]

What happens if CTLA-4 is inhibited? [1]

A

CTLA-4 suppressed T cell activation and inhibits cell function; plays a role in T-cell priming

Inhibiting CTLA-4 ”takes the breaks off” the immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name two drugs that inhibit CTLA-4

A

Ipilimubab
Tremelimubab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the difference between chimeric and humanised monoclonal antibodies? [2]

A

- chimeric: Monoclonal antibody with a large stretch of non-human proteins
- humanized: Monoclonal antibody coupled with a human Ig backbone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the three ways that monoclonal antibodies are broadly used? [3]

A

Complement mediated lysis: unconjugated
Immunotoxins: Coupled to toxin
Radioimmunoconjugates: Coupled to radioisotopes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Give an example that is a chimeric monoclonal antibody used for treating B-Lymphomas [1]

What is the target? [2]

A

Rituximab: targets CD20 on malignant B-cells and CD3 on normal T cells

Together enhance cytotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are Chimeric antigen receptors? [1]

A

Chimeric antigen receptors (CARs): are recombinant receptors for antigens which redirect the specificity and function of T lymphocytes and/or other immune cells in a single molecule.

(Chimeric antigen receptors: on the surface we have the antibody components so the T cells are recognised by the antigen on the tumour cells, and 2nd and 3rd generation CARs have additional costimulatory molecules to enhance the immune response)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain the mechanism of how chimeric antigen receptor treatment occurs [3]

A

Take T cells

Retrovirally transfect them to be able to express the chimeric antigen whereby you have the antibody on the surface linked into the molecule that activates the T cell

(T cells are removed from a cancer patient and modified so they express receptor specific to the patient’s cancer, then are reintroduced to patient)

T cell then recognises the tumour cell and that activated tumour cell kills off these cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Give an example of CAR-T drug for targetting large B-cell lymphoma? [1]

What is the drug target? [1]

A

Tisagenlecleucel (Kymriah)

CAR-T Cell targeting CD19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The patient is enrolled in a clinical trial of chimeric antigen receptor-engineered T cells (CAR-T cells). So far, in the early clinical trials, chimeric antigen receptor-engineered T cells (CAR-T cells) have targeted which receptor in the treatment of acute lymphoblastic leukemia?

A. CD5
B. CD19
C. CD45
D. CD99

A

The patient is enrolled in a clinical trial of chimeric antigen receptor-engineered T cells (CAR-T cells). So far, in the early clinical trials, chimeric antigen receptor-engineered T cells (CAR-T cells) have targeted which receptor in the treatment of acute lymphoblastic leukemia?

A. CD5
B. CD19
C. CD45
D. CD99

17
Q

What is the point of using immunotherapy biomarkers? [1]

Name 3 key biomarkers for immunotherapy

A

All cancer treatment comes with AES. If can ID patients who will likely have least AEs then best cost / benefit: using biomarkers can try and ID.

General immune status (how many T cells are in the tumour)
Absence of checkpoints
Tumour insensitivty to immune effectors

(listen over quickly)

18
Q

neoantigen load xxx

A
19
Q

Name 5 future immunotherapy treatments

A

Microbiome: faecal microbiota transplant treated checkpoint inhibition

ECM: cancerous cells can manipulate the immune system so they can change what type of collagen is in the matrix (and make it an easier place for them to live). Can change the type of collagen or structure in our immune system to combat the cancer

Adaptive T cell therapy: Priming - generation a new immune response; Boosting of immune memory

Adpotive cell transfer:

Dendritic Cell Vaccination